Literature DB >> 8243836

Ulcerative colitis serum recognizes the M(r) 40K protein on colonic adenocarcinoma cells for antibody-dependent cellular cytotoxicity.

L Biancone1, K M Das, A I Roberts, E C Ebert.   

Abstract

Antibodies in ulcerative colitis (UC) serum promote antibody-dependent cellular cytotoxicity (ADCC) against colon cancer cells. The target molecules on the cells recognized by the antibody are unknown. This study examines the role of the M(r) 40K colon epithelial protein in this process. Serum from 29 UC patients, but not from 19 patients with Crohn's disease, significantly (p < 0.001) induced more cytotoxicity than did normal serum against DLD-1 colon cancer cells which are known to express the M(r) 40K protein. Peripheral blood lymphocytes but not polymorphonuclear leukocytes showed ADCC. Anti-M(r) 40K monoclonal antibodies significantly (p < 0.001) inhibited the UC-serum-induced ADCC, but not the spontaneous cytotoxicity. These results suggest the involvement of the M(r) 40K protein in ADCC induced by UC serum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243836     DOI: 10.1159/000201043

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  Circulating immunoglobulin G1 antibody in patients with ulcerative colitis against the colonic epithelial protein detected by a novel monoclonal antibody.

Authors:  A Dasgupta; A Mandal; K M Das
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

2.  Expression of a unique protein on colon cancer cells that reacts with a novel monoclonal antibody and ulcerative colitis serum.

Authors:  T Hassan; Y Kanisawa; S Meyers; A Dasgupta; K M Das
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

3.  99mTc-HMPAO granulocyte scintigraphy in the early detection of postoperative asymptomatic recurrence in Crohn's disease.

Authors:  L Biancone; F Scopinaro; M Ierardi; P Paoluzi; A Marcheggiano; M C Di Paolo; B Porowska; A C Colella; F Pallone
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.